Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635
GH Stock | USD 38.00 0.95 2.56% |
Under 57% of all Guardant Health's traders are looking to take a long position. The analysis of overall sentiment of trading Guardant Health stock suggests that some investors are interested at this time. Guardant Health's investing sentiment shows overall attitude of investors towards Guardant Health.
Guardant Health, Inc. , a leading precision oncology company, today announced that on October 22, 2024, the Compensation Committee of Guar
Read at businesswire.com
![]() |
Guardant Health Maximum Pain Price Across July 18th 2025 Option Contracts
Guardant Health's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Guardant Health close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Guardant Health's options.
Guardant Health Fundamental Analysis
We analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Guardant Health is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Guardant Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardant Health stock to make a market-neutral strategy. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics with similar companies.
Peers
Guardant Health Related Equities
MYGN | Myriad Genetics | 6.14 | ||||
CDNA | CareDx | 4.01 | ||||
NTRA | Natera | 2.50 | ||||
CRL | Charles River | 0.83 | ||||
TWST | Twist Bioscience | 0.36 | ||||
ILMN | Illumina | 0.21 | ||||
A | Agilent Technologies | 1.05 | ||||
DHR | Danaher | 1.57 | ||||
TMO | Thermo Fisher | 1.70 | ||||
CSTL | Castle Biosciences | 1.86 | ||||
PSNL | Personalis | 1.88 |
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world |